Retinoic acid receptor alpha, Retinoic acid receptor beta isoform 2, and Retinoic acid receptor gamma (RARα, RARβ2, RARγ)

Retinoic acid receptors (RARs) are a group of nuclear receptors—comprising RARα, RARβ, and RARγ—that function as ligand-activated transcription factors to mediate the biological effects of vitamin A derivatives known as retinoids [1, 6]. These receptors are essential for regulating diverse processes, including embryonic development, cell differentiation, and tissue homeostasis [4, 7]. RARα is widely expressed and plays a critical role in myeloid development; its fusion with the PML protein is the primary driver of acute promyelocytic leukemia (APL) [3, 11]. RARβ, particularly the RARβ2 isoform, is recognized as a potent tumor suppressor that is frequently silenced in various cancers through epigenetic mechanisms such as promoter methylation [2, 9]. RARγ is the dominant subtype in the skin and is also involved in skeletal development, making it a key target for dermatological conditions and rare bone diseases like fibrodysplasia ossificans progressiva [10, 13]. Retinoid drugs, such as tretinoin and palovarotene, modulate these receptors to treat malignancies and skin disorders, though their therapeutic use is strictly controlled due to severe teratogenic risks [1, 13].

Other names

Retinoic acid receptor alphaRetinoic acid receptor beta isoform 2Retinoic acid receptor gammaRAR-alphaRAR-beta2RAR-gammaRARARARBRARGNR1B1NR1B2NR1B3

Retinoid drugs function as ligands that bind to the retinoic acid receptors, acting primarily as agonists to induce transcriptional activity [1, 10]. Upon ligand binding, the RARs undergo a conformational change that facilitates heterodimerization with Retinoid X Receptors (RXRs) [6, 7]. This heterodimer binds to specific DNA sequences known as Retinoic Acid Response Elements (RAREs) located in the promoter regions of target genes [3, 9]. The complex then recruits coactivator proteins and chromatin remodeling factors, leading to the activation of gene transcription for processes such as cell differentiation and apoptosis [2, 5]. Conversely, in the absence of a ligand or in the presence of an antagonist, the receptors recruit corepressors to maintain gene silencing [6, 11].